These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24032423)

  • 1. Non-invasive detection of neurochemical changes prior to overt pathology in a mouse model of spinocerebellar ataxia type 1.
    Emir UE; Brent Clark H; Vollmers ML; Eberly LE; Öz G
    J Neurochem; 2013 Dec; 127(5):660-8. PubMed ID: 24032423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice.
    Oz G; Vollmers ML; Nelson CD; Shanley R; Eberly LE; Orr HT; Clark HB
    Exp Neurol; 2011 Dec; 232(2):290-8. PubMed ID: 21963649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
    Oz G; Nelson CD; Koski DM; Henry PG; Marjanska M; Deelchand DK; Shanley R; Eberly LE; Orr HT; Clark HB
    J Neurosci; 2010 Mar; 30(10):3831-8. PubMed ID: 20220018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1.
    Venkatraman A; Hu YS; Didonna A; Cvetanovic M; Krbanjevic A; Bilesimo P; Opal P
    Hum Mol Genet; 2014 Jul; 23(14):3733-45. PubMed ID: 24594842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model.
    Watase K; Gatchel JR; Sun Y; Emamian E; Atkinson R; Richman R; Mizusawa H; Orr HT; Shaw C; Zoghbi HY
    PLoS Med; 2007 May; 4(5):e182. PubMed ID: 17535104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing recovery from neurodegeneration in spinocerebellar ataxia 1: Comparison of in vivo magnetic resonance spectroscopy with motor testing, gene expression and histology.
    Öz G; Kittelson E; Demirgöz D; Rainwater O; Eberly LE; Orr HT; Clark HB
    Neurobiol Dis; 2015 Feb; 74():158-66. PubMed ID: 25446943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities in synaptic dynamics during development in a mouse model of spinocerebellar ataxia type 1.
    Hatanaka Y; Watase K; Wada K; Nagai Y
    Sci Rep; 2015 Nov; 5():16102. PubMed ID: 26531852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
    Cummings CJ; Orr HT; Zoghbi HY
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice.
    Skinner PJ; Vierra-Green CA; Emamian E; Zoghbi HY; Orr HT
    Neuromolecular Med; 2002; 1(1):33-42. PubMed ID: 12025814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis.
    Crespo-Barreto J; Fryer JD; Shaw CA; Orr HT; Zoghbi HY
    PLoS Genet; 2010 Jul; 6(7):e1001021. PubMed ID: 20628574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF is altered in a brain-region specific manner and rescues deficits in Spinocerebellar Ataxia Type 1.
    Rosa JG; Hamel K; Soles A; Sheeler C; Borgenheimer E; Gilliat S; Sbrocco K; Ghanoum F; Handler HP; Forster C; Rainwater O; Cvetanovic M
    Neurobiol Dis; 2023 Mar; 178():106023. PubMed ID: 36724861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration.
    Watase K; Weeber EJ; Xu B; Antalffy B; Yuva-Paylor L; Hashimoto K; Kano M; Atkinson R; Sun Y; Armstrong DL; Sweatt JD; Orr HT; Paylor R; Zoghbi HY
    Neuron; 2002 Jun; 34(6):905-19. PubMed ID: 12086639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebellar Heterogeneity and Selective vulnerability in Spinocerebellar Ataxia Type 1 (SCA1).
    Hamel K; Moncada EL; Sheeler C; Rosa JG; Gilliat S; Zhang Y; Cvetanovic M
    Neurobiol Dis; 2024 Jul; 197():106530. PubMed ID: 38750673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinocerebellar ataxia type 1--modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice.
    Clark HB; Orr HT
    J Neuropathol Exp Neurol; 2000 Apr; 59(4):265-70. PubMed ID: 10759181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellar contribution to the cognitive alterations in SCA1: evidence from mouse models.
    Asher M; Rosa JG; Rainwater O; Duvick L; Bennyworth M; Lai RY; ; Kuo SH; Cvetanovic M
    Hum Mol Genet; 2020 Jan; 29(1):117-131. PubMed ID: 31696233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focused cerebellar laser light induced hyperthermia improves symptoms and pathology of polyglutamine disease SCA1 in a mouse model.
    Hearst SM; Shao Q; Lopez M; Raucher D; Vig PJ
    Cerebellum; 2014 Oct; 13(5):596-606. PubMed ID: 24930030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability.
    Dell'Orco JM; Wasserman AH; Chopra R; Ingram MA; Hu YS; Singh V; Wulff H; Opal P; Orr HT; Shakkottai VG
    J Neurosci; 2015 Aug; 35(32):11292-307. PubMed ID: 26269637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy.
    Keiser MS; Boudreau RL; Davidson BL
    Mol Ther; 2014 Mar; 22(3):588-595. PubMed ID: 24419082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel function of Ataxin-1 in the modulation of PP2A activity is dysregulated in the spinocerebellar ataxia type 1.
    Sánchez I; Piñol P; Corral-Juan M; Pandolfo M; Matilla-Dueñas A
    Hum Mol Genet; 2013 Sep; 22(17):3425-37. PubMed ID: 23630944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy.
    Vig PJ; Hearst S; Shao Q; Lopez ME; Murphy HA; Safaya E
    Cerebellum; 2011 Jun; 10(2):254-66. PubMed ID: 21384195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.